Precipio, Inc. — Director's Dealing 2016

Dec 15, 2016

SEC Form 4/A — Form 4/A

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2016-12-13

Reporting Person: Koppler Doit II (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-13	Option to Purchase Common Stock	$0.34	A	5000	Acquired	2026-12-13	Common Stock (5000)	Direct

Footnotes

F1: This stock option was originally granted pursuant to the Company's 2006 Equity Incentive Plan, as amended (the "2006 Plan") on October 6, 2016 (the "Grant"). On December 13, 2016, the Board of Directors of the Company (the "Board") approved the 2016 Stock Option and Incentive Plan (the "2016 Plan") and recommended the 2016 Plan for approval by the Company's stockholders. The 2016 Plan is intended to serve as a successor to and replacement for the 2006 Plan. Also on December 13, 2016, the Board re-issued the Grant pursuant to the 2016 Plan, subject to the approval of the 2016 Plan by the Company's stockholders. This amended Form 4 reflects this re-issuance.